Syndax Pharmaceuticals In...

NASDAQ: SNDX · Real-Time Price · USD
15.71
0.98 (6.65%)
At close: Aug 15, 2025, 3:59 PM
15.97
1.69%
After-hours: Aug 15, 2025, 06:30 PM EDT

Syndax Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-334.99M -331.2M -318.76M -297.06M -264.08M -240.63M -209.36M -176.08M -160.34M -153.29M -149.34M -13.95M 818K 15.48M 24.93M -91.69M -91.49M -85.64M
Depreciation & Amortization
169K 117K 8K 11K 12K 12K 12K 12K 17K 25K 33K 40K 40K 38K 43K 54K 69K 82K
Stock-Based Compensation
48.4M 44.51M 43.03M 39.06M 35.44M 33.61M 30.95M 26.86M 22.91M 18.78M 16.02M 15.71M 14.73M 14.03M 13.32M 11.42M 11.11M 9.99M
Other Working Capital
33.7M 28.82M 22.84M 18.48M 14.18M 20.88M 26.25M 20.88M 16.32M 9.62M 2.98M -13.04M -24.59M -21.59M -11.76M -9.69M -3.27M -841K
Other Non-Cash Items
-56.06M -14.58M 18.46M 10.57M 13.57M 2.03M -14.06M -5.38M -5.77M -5.66M -1.78M -337K 36K -6K 187K 876K 868K 861K
Deferred Income Tax
n/a n/a n/a 7.38M 3.72M n/a n/a -7.38M -3.72M n/a n/a -218K -45K 142K 255K 538K 363K 93K
Change in Working Capital
39.82M 29.74M 13.27M 12.09M 1.05M 15.87M 31.86M 19.82M 20.86M 9.44M 1.66M -11.05M -21.78M -19.89M -9.6M -8.4M -1.47M -3.31M
Operating Cash Flow
-302.67M -286.52M -274.9M -258.86M -241.19M -204.92M -160.6M -142.15M -126.04M -130.97M -133.68M -10.07M -6.47M 9.79M 29.13M -87.21M -80.56M -77.92M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a -225K -225K -225K -354K -129K -129K -129K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a 225K 225K 225K 225K n/a n/a n/a n/a n/a n/a
Purchase of Investments
-491.92M -400.2M -557.05M -310.03M -379.4M -460.41M -354.61M -476.19M -473.31M -514.66M -495.35M -349.69M -332.8M -270.26M -294.72M -318.08M -274.36M -310.73M
Sales Maturities Of Investments
445.82M 373.97M 337.28M 342.94M 365.54M 458.7M 472.21M 472.46M 422.48M 339.99M 308.93M 241.08M 257.84M 266.92M 253.97M 273.02M 221.95M 158.02M
Other Investing Acitivies
n/a 61.75M -37.65M -53.94M -13.86M -1.71M 117.61M -3.73M -43.58M -167.44M -179.17M -101.37M -74.96M -3.33M -40.74M -45.06M -52.41M -152.71M
Investing Cash Flow
-46.1M -26.23M -219.78M 32.91M -13.86M -1.71M 117.61M -3.73M -50.6M -174.46M -186.19M -108.52M -75.09M -3.46M -40.87M -45.06M -52.41M -152.71M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a 2K 2K 2K 2K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
352M 352.13M 353.37M 6.33M 5.08M 5.73M 6.04M 6.79M -8.59M 11.8M 9.89M 37.33M 52.55M 31.72M 32.13M 7.23M 7.29M 7.5M
Financial Cash Flow
352M 352.13M 353.37M 264.43M 263.18M 263.83M 264.13M 169.15M 153.78M 174.17M 172.25M 118.53M 133.76M 118.06M 118.46M 147.34M 147.41M 250.39M
Net Cash Flow
3.46M 39.59M -141.09M 38.69M 8.12M 57.2M 221.14M 23.27M -22.86M -131.26M -147.61M -56K 52.2M 124.39M 106.72M 15.08M 14.43M 19.76M
Free Cash Flow
-302.67M -286.52M -274.9M -258.86M -241.19M -204.92M -160.6M -142.15M -126.26M -131.2M -133.9M -10.43M -6.6M 9.66M 29M -87.21M -80.56M -77.92M